Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Salvatore Cottone

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 12, 2021
Menstrual cycle resumption and female fertility after autologous hematopoietic stem cell transplantation for multiple sclerosisClaudia Massarotti, Elvira Sbragia, Giacomo Boffa, et al.
Frontiers in Neurology|May 10, 2021
Multicenter Interventional Phase IV Study for the Assessment of the Effects on Patient's Satisfaction of Peg IFN Beta-1a (Pre-filled Pen) in Subjects With Relapsing-Remitting Multiple Sclerosis Unsatisfied With Other Injectable Subcutaneous Interferons (PLATINUM Study)Diego Centonze, Roberta Fantozzi, Fabio Buttari, et al.
Current Neuropharmacology|March 22, 2023
Real-World Effectiveness of Cladribine for Patients with Multiple Sclerosis: A Sicilian Multicentric Experience (Rewind Study)Sebastiano Arena, Clara Grazia Chisari, Simona Toscano, et al.
BMC Neurology|March 7, 2012
Patient adherence to and tolerability of self-administered interferon β-1a using an electronic autoinjection device: a multicentre, open-label, phase IV studyAlessandra Lugaresi, Ciro Florio, Vincenzo Brescia-Morra, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 16, 2025
Real-world effectiveness and safety of ofatumumab in relapsing-remitting multiple sclerosis: Insights from naïve and switch patientsClara G Chisari, Salvatore Lo Fermo, Salvatore Iacono, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 17, 2022
Unmet needs and gaps in the identification of secondary progression in multiple sclerosis: a Southern Italy healthcare professionals' perspectiveGiacomo Lus, Marco André Bassano, Vincenzo Brescia Morra, et al.
Therapeutic Advances in Neurological Disorders|September 14, 2018
Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experienceEmanuele D'Amico, Aurora Zanghì, Graziella Callari, et al.
Neurology|January 21, 2021
Long-term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple SclerosisGiacomo Boffa, Luca Massacesi, Matilde Inglese, et al.
Plos One|August 2, 2017
Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study)Silvia Messina, Claudio Solaro, Isabella Righini, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|May 7, 2024
Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched studyClara G Chisari, Umberto Aguglia, Maria Pia Amato, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 12, 2021
Menstrual cycle resumption and female fertility after autologous hematopoietic stem cell transplantation for multiple sclerosisClaudia Massarotti, Elvira Sbragia, Giacomo Boffa, et al.
Frontiers in Neurology|May 10, 2021
Multicenter Interventional Phase IV Study for the Assessment of the Effects on Patient's Satisfaction of Peg IFN Beta-1a (Pre-filled Pen) in Subjects With Relapsing-Remitting Multiple Sclerosis Unsatisfied With Other Injectable Subcutaneous Interferons (PLATINUM Study)Diego Centonze, Roberta Fantozzi, Fabio Buttari, et al.
Current Neuropharmacology|March 22, 2023
Real-World Effectiveness of Cladribine for Patients with Multiple Sclerosis: A Sicilian Multicentric Experience (Rewind Study)Sebastiano Arena, Clara Grazia Chisari, Simona Toscano, et al.
BMC Neurology|March 7, 2012
Patient adherence to and tolerability of self-administered interferon β-1a using an electronic autoinjection device: a multicentre, open-label, phase IV studyAlessandra Lugaresi, Ciro Florio, Vincenzo Brescia-Morra, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 16, 2025
Real-world effectiveness and safety of ofatumumab in relapsing-remitting multiple sclerosis: Insights from naïve and switch patientsClara G Chisari, Salvatore Lo Fermo, Salvatore Iacono, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 17, 2022
Unmet needs and gaps in the identification of secondary progression in multiple sclerosis: a Southern Italy healthcare professionals' perspectiveGiacomo Lus, Marco André Bassano, Vincenzo Brescia Morra, et al.
Therapeutic Advances in Neurological Disorders|September 14, 2018
Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experienceEmanuele D'Amico, Aurora Zanghì, Graziella Callari, et al.
Neurology|January 21, 2021
Long-term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple SclerosisGiacomo Boffa, Luca Massacesi, Matilde Inglese, et al.
Plos One|August 2, 2017
Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study)Silvia Messina, Claudio Solaro, Isabella Righini, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|May 7, 2024
Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched studyClara G Chisari, Umberto Aguglia, Maria Pia Amato, et al.
Pageof 3